TCL Archive ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer June 5, 1998
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012